Jeff Yass’s Opus Genetics IRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q3 | $1.69M | Buy |
350,141
+153,244
| +78% | +$636K | ﹤0.01% | 6669 |
|
|
2026
Q2 | $809K | Sell |
196,897
-626,486
| -76% | -$2.92M | ﹤0.01% | 8756 |
|
|
2026
Q1 | $3.75M | Buy |
823,383
+621,748
| +308% | +$2.15M | ﹤0.01% | 4803 |
|
|
2025
Q4 | $405K | Buy |
201,635
+181,422
| +898% | +$368K | ﹤0.01% | 9263 |
|
|
2025
Q3 | $33.4K | Buy |
20,213
+2,910
| +17% | +$3.62K | ﹤0.01% | 11959 |
|
|
2025
Q2 | $16.3K | Sell |
17,303
-5,796
| -25% | -$5.37K | ﹤0.01% | 12362 |
|
|
2025
Q1 | $22.7K | Buy |
+23,099
| New | +$25.8K | ﹤0.01% | 12079 |
|
|
2024
Q4 | – | Sell |
-49,755
| Closed | -$65.2K | – | 13466 |
|
|
2024
Q3 | $65.2K | Buy |
49,755
+3,178
| +7% | +$4.89K | ﹤0.01% | 11275 |
|
|
2024
Q2 | $71.3K | Buy |
46,577
+3,987
| +9% | +$6.89K | ﹤0.01% | 11235 |
|
|
2024
Q1 | $85.6K | Buy |
42,590
+20,385
| +92% | +$51.7K | ﹤0.01% | 11302 |
|
|
2023
Q4 | $66.8K | Sell |
22,205
-33,795
| -60% | -$100K | ﹤0.01% | 11578 |
|
|
2023
Q3 | $188K | Buy |
+56,000
| New | +$225K | ﹤0.01% | 10300 |
|
|
2023
Q2 | – | Sell |
-14,751
| Closed | -$70K | – | 13337 |
|
|
2023
Q1 | $55.3K | Sell |
14,751
-15,451
| -51% | -$55.5K | ﹤0.01% | 11659 |
|
|
2022
Q4 | $107K | Sell |
30,202
-6,391
| -17% | -$16.8K | ﹤0.01% | 10908 |
|
|
2022
Q3 | $74K | Sell |
36,593
-8,040
| -18% | -$17.3K | ﹤0.01% | 11953 |
|
|
2022
Q2 | $86K | Sell |
44,633
-7,490
| -14% | -$17K | ﹤0.01% | 11614 |
|
|
2022
Q1 | $169K | Sell |
52,123
-11,356
| -18% | -$38.9K | ﹤0.01% | 11443 |
|
|
2021
Q4 | $237K | Buy |
63,479
+22,685
| +56% | +$90.9K | ﹤0.01% | 11069 |
|
|
2021
Q3 | $210K | Sell |
40,794
-18,378
| -31% | -$84.7K | ﹤0.01% | 11388 |
|
|
2021
Q2 | $312K | Buy |
+59,172
| New | +$294K | ﹤0.01% | 10703 |
|
|
2018
Q1 | – | Sell |
-380
| Closed | -$37K | – | 10332 |
|
|
2017
Q4 | $37K | Buy |
+380
| New | +$38.6K | ﹤0.01% | 8987 |
|
|
2017
Q3 | – | Sell |
-21,163
| Closed | -$2.9M | – | 9759 |
|
|
2017
Q2 | $2.9M | Buy |
+21,163
| New | +$4.11M | ﹤0.01% | 3214 |
|
|
2016
Q1 | – | Sell |
-38
| Closed | -$7K | – | 9781 |
|
|
2015
Q4 | $7K | Buy |
+38
| New | +$8.08K | ﹤0.01% | 9308 |
|
|
2015
Q2 | – | Sell |
-31
| Closed | -$11K | – | 10530 |
|
|
2015
Q1 | $11K | Sell |
31
-76
| -71% | -$27.6K | ﹤0.01% | 9305 |
|
|
2014
Q4 | $36K | Buy |
+107
| New | +$36.9K | ﹤0.01% | 9426 |
|
Other funds holding IRD
Jeff Yass's IRD Position: Q3 2026 in Review
Jeff Yass increased its Opus Genetics (IRD) stake by 78% in Q3 2026, buying an estimated $636K and bringing the position to 350,141 shares worth $1.69M. The position accounts for ﹤0.01% of the portfolio, ranked #6669.
Jeff Yass first reported a position in IRD in Q4 2014 and has held it in 25 quarters since. The position peaked at $3.75M in Q1 2026. 112 funds tracked by Wall St. Rank hold IRD as of Q3 2026.
- Jeff Yass held 350,141 shares of Opus Genetics worth $1.69M as of Q3 2026.
- Jeff Yass bought 153,244 Opus Genetics shares in Q3 2026, an estimated $636K.
- Opus Genetics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #6669 holding.
- Jeff Yass first reported a position in Opus Genetics in Q4 2014 and has held it in 25 quarters since.
- Jeff Yass's Opus Genetics position peaked at $3.75M in Q1 2026.
- 112 funds tracked by Wall St. Rank held Opus Genetics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.